Upregulation of ephrin-B2/EphB4 has been observed in many tumors, including ovary, colon, breast, and glioma, with a strong correlation with poor prognosis [14], [15], [16], [17], [18], [23], [24]. This evidence concerns the gene EPHB4 and central nervous system cancer.